Literature DB >> 22865455

CD133+ melanoma subpopulations contribute to perivascular niche morphogenesis and tumorigenicity through vasculogenic mimicry.

Chiou-Yan Lai1, Brian E Schwartz, Mei-Yu Hsu.   

Abstract

Tumor cell subpopulations that express cancer stem cell markers such as CD133 (prominin1) or ABCB5 are thought to be crucial for tumor initiation and heterogeneity, but their biological significance in melanoma has been controversial. Here, we report that CD133(+) and ABCB5(+) subpopulations are colocalized in melanomas in perivascular niches that contain CD144 (VE-cadherin)(+) melanoma cells forming vessel-like channels, a phenomenon termed vasculogenic mimicry (VM). RNAi-mediated attenuation of CD133 established its critical function in morphogenesis of these perivascular niches as well as in melanoma tumorigenicity. Niche-associated genes CD144 and ABCB5 were downregulated in tumors derived from CD133 knockdown (KD) melanoma cells compared with controls. CD133KD cells also lacked the ability to form CD144(+) VM-like channels in a manner that was associated with a depletion of the ABCB5(+) cell subpopulation. Finally, CD133 KD cells exhibited poorer tumor growth in vivo. Taken together, our findings corroborate models in which CD133(+)/ABCB5(+) melanoma cells reside in a complex anastomosing microvascular niche that encompasses CD144(+) VM channels as well as authentic endothelial cell-lined blood vessels. Further, they indicate that CD133(+) cells act as stem-like cells, which drive tumor growth by promoting VM and the morphogenesis of a specialized perivascular niche in melanoma. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22865455      PMCID: PMC3463654          DOI: 10.1158/0008-5472.CAN-12-0624

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Neuroscience. Cellular interactions in the stem cell niche.

Authors:  Andrew E Wurmser; Theo D Palmer; Fred H Gage
Journal:  Science       Date:  2004-05-28       Impact factor: 47.728

3.  A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.

Authors:  Alexander Roesch; Mizuho Fukunaga-Kalabis; Elizabeth C Schmidt; Susan E Zabierowski; Patricia A Brafford; Adina Vultur; Devraj Basu; Phyllis Gimotty; Thomas Vogt; Meenhard Herlyn
Journal:  Cell       Date:  2010-05-14       Impact factor: 41.582

4.  CD133+ cells with cancer stem cell characteristics associates with vasculogenic mimicry in triple-negative breast cancer.

Authors:  T J Liu; B C Sun; X L Zhao; X M Zhao; T Sun; Q Gu; Z Yao; X Y Dong; N Zhao; N Liu
Journal:  Oncogene       Date:  2012-04-02       Impact factor: 9.867

5.  VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.

Authors:  Natasha Y Frank; Tobias Schatton; Soo Kim; Qian Zhan; Brian J Wilson; Jie Ma; Karim R Saab; Veronika Osherov; Hans R Widlund; Martin Gasser; Ana-Maria Waaga-Gasser; Thomas S Kupper; George F Murphy; Markus H Frank
Journal:  Cancer Res       Date:  2011-01-06       Impact factor: 12.701

6.  Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.

Authors:  Mei-Yu Hsu; Sherry A Rovinsky; Chiou-Yan Lai; Shadi Qasem; Xiaoming Liu; Joan How; John F Engelhardt; George F Murphy
Journal:  Lab Invest       Date:  2008-06-16       Impact factor: 5.662

7.  CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells.

Authors:  Jian Wang; Per Ø Sakariassen; Oleg Tsinkalovsky; Heike Immervoll; Stig Ove Bøe; Agnete Svendsen; Lars Prestegarden; Gro Røsland; Frits Thorsen; Linda Stuhr; Anders Molven; Rolf Bjerkvig; Per Ø Enger
Journal:  Int J Cancer       Date:  2008-02-15       Impact factor: 7.396

8.  Nodal as a biomarker for melanoma progression and a new therapeutic target for clinical intervention.

Authors:  Luigi Strizzi; Lynne-Marie Postovit; Naira V Margaryan; Alina Lipavsky; Jules Gadiot; Christian Blank; Richard Eb Seftor; Elisabeth A Seftor; Mary Jc Hendrix
Journal:  Expert Rev Dermatol       Date:  2009

Review 9.  Cancer stem cells and human malignant melanoma.

Authors:  Tobias Schatton; Markus H Frank
Journal:  Pigment Cell Melanoma Res       Date:  2008-02       Impact factor: 4.693

10.  Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures.

Authors:  Klara Valyi-Nagy; Bernadett Kormos; Mohamed Ali; Deepak Shukla; Tibor Valyi-Nagy
Journal:  Mol Vis       Date:  2012-03-02       Impact factor: 2.367

View more
  49 in total

1.  Vasculogenic mimicry and aberrant expression of HIF-lα/E-cad are associated with worse prognosis of esophageal squamous cell carcinoma.

Authors:  Da-Min Chai; Zheng-Qi Bao; Jian-Guo Hu; Li Ma; Zhen-Zhong Feng; Yi-Sheng Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2013-06-17

2.  Malignant perivascular melanoma mimicking primary central nervous system vasculitis.

Authors:  Martin Schneider; Jan Höltje; Uwe Kehler; Volker Hartmann; Konstanze Holl-Ullrich; Katrin Oechel; Peter Paul Urban
Journal:  J Neurol       Date:  2012-12-20       Impact factor: 4.849

3.  Cancer stem cells in glioma: challenges and opportunities.

Authors:  Jialiang Wang; Yufang Ma; Michael K Cooper
Journal:  Transl Cancer Res       Date:  2013-10-01       Impact factor: 1.241

4.  Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.

Authors:  Alex Panaccione; Yan Guo; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Clin Breast Cancer       Date:  2017-01-27       Impact factor: 3.225

5.  Association of Notch1 with vasculogenic mimicry in human hepatocellular carcinoma cell lines.

Authors:  Man-Sheng Zhu; Lei-Bo Xu; Hong Zeng; Xiang-De Shi; Wen-Rui Wu; Chao Liu
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

Review 6.  Melanoma tumor cell heterogeneity: a molecular approach to study subpopulations expressing the embryonic morphogen nodal.

Authors:  Elisabeth A Seftor; Richard E B Seftor; Don Weldon; Gina T Kirsammer; Naira V Margaryan; Alina Gilgur; Mary J C Hendrix
Journal:  Semin Oncol       Date:  2014-02-07       Impact factor: 4.929

7.  Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.

Authors:  Catherine A A Lee; Pallavi Banerjee; Brian J Wilson; Siyuan Wu; Qin Guo; Gretchen Berg; Svetlana Karpova; Ananda Mishra; John W Lian; Johnathan Tran; Max Emmerich; George F Murphy; Markus H Frank; Natasha Y Frank
Journal:  J Biol Chem       Date:  2020-04-20       Impact factor: 5.157

Review 8.  Cancer Stem Cells: The Architects of the Tumor Ecosystem.

Authors:  Briana C Prager; Qi Xie; Shideng Bao; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2019-01-03       Impact factor: 24.633

Review 9.  CD133-targeted niche-dependent therapy in cancer: a multipronged approach.

Authors:  Anthony B Mak; Caroline Schnegg; Chiou-Yan Lai; Subrata Ghosh; Moon Hee Yang; Jason Moffat; Mei-Yu Hsu
Journal:  Am J Pathol       Date:  2014-02-28       Impact factor: 4.307

10.  Induction of Vasculogenic Mimicry Overrides VEGF-A Silencing and Enriches Stem-like Cancer Cells in Melanoma.

Authors:  Caroline I Schnegg; Moon Hee Yang; Subrata K Ghosh; Mei-Yu Hsu
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.